[go: up one dir, main page]

DK1365749T3 - Fremgangsmåde til fremstilling af farmaceutiske sammensætninger til anvendelse i blöde gelformuleringer - Google Patents

Fremgangsmåde til fremstilling af farmaceutiske sammensætninger til anvendelse i blöde gelformuleringer

Info

Publication number
DK1365749T3
DK1365749T3 DK01984557T DK01984557T DK1365749T3 DK 1365749 T3 DK1365749 T3 DK 1365749T3 DK 01984557 T DK01984557 T DK 01984557T DK 01984557 T DK01984557 T DK 01984557T DK 1365749 T3 DK1365749 T3 DK 1365749T3
Authority
DK
Denmark
Prior art keywords
active ingredient
pharmaceutically active
concentration
preparation
dosage
Prior art date
Application number
DK01984557T
Other languages
Danish (da)
English (en)
Inventor
Stephen Charles Tindal
Christopher Clive Webster
Josephine Christine Ferdinando
Jacqueline Carol Lewis
Original Assignee
Scherer Technologies Inc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24606884&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1365749(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Scherer Technologies Inc R P filed Critical Scherer Technologies Inc R P
Application granted granted Critical
Publication of DK1365749T3 publication Critical patent/DK1365749T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK01984557T 2000-08-29 2001-08-28 Fremgangsmåde til fremstilling af farmaceutiske sammensætninger til anvendelse i blöde gelformuleringer DK1365749T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/649,947 US6387400B1 (en) 2000-08-29 2000-08-29 Process for preparing pharmaceutical compositions for use with soft gelatin formulations
PCT/US2001/026711 WO2002017855A2 (fr) 2000-08-29 2001-08-28 Preparation de compositions pharmaceutiques a utiliser avec des formulations gelatineuses molles

Publications (1)

Publication Number Publication Date
DK1365749T3 true DK1365749T3 (da) 2007-06-04

Family

ID=24606884

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01984557T DK1365749T3 (da) 2000-08-29 2001-08-28 Fremgangsmåde til fremstilling af farmaceutiske sammensætninger til anvendelse i blöde gelformuleringer

Country Status (23)

Country Link
US (1) US6387400B1 (fr)
EP (1) EP1365749B1 (fr)
JP (1) JP4990474B2 (fr)
KR (1) KR100634571B1 (fr)
CN (1) CN1237959C (fr)
AT (1) ATE353009T1 (fr)
AU (2) AU2002224317B2 (fr)
BR (1) BRPI0113539B8 (fr)
CA (1) CA2419993C (fr)
CY (1) CY1106542T1 (fr)
CZ (1) CZ299449B6 (fr)
DE (2) DE60126433T2 (fr)
DK (1) DK1365749T3 (fr)
ES (1) ES2206081T3 (fr)
HU (1) HU229381B1 (fr)
MX (1) MXPA03001762A (fr)
NO (1) NO333369B1 (fr)
PL (1) PL200398B1 (fr)
PT (1) PT1365749E (fr)
SI (1) SI1365749T1 (fr)
TW (1) TW589199B (fr)
WO (1) WO2002017855A2 (fr)
ZA (1) ZA200301007B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4226846B2 (ja) * 2002-06-07 2009-02-18 キャタレント・ジャパン株式会社 口腔内で崩壊可能なソフトカプセル剤
WO2005046727A2 (fr) * 2003-11-12 2005-05-26 Ranbaxy Laboratories Limited Capsules gelatineuses molles renfermant de l'ibuprofene
US9241902B2 (en) * 2003-12-17 2016-01-26 R.P. Scherer Technologies, Llc Chewable soft capsules containing ungelatinized starch
US20050137262A1 (en) * 2003-12-22 2005-06-23 Hu Patrick C. Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses
WO2005063219A2 (fr) * 2003-12-23 2005-07-14 Ranbaxy Laboratories Limited Capsules en gelatine molle contenant de l'ibuprofene
JP2007517884A (ja) * 2004-01-09 2007-07-05 ワイス 医薬組成物用のマイクロエマルジョン
US20050249802A1 (en) * 2004-05-06 2005-11-10 The Procter & Gamble Company Softgel encapsulated pharmaceutical compositions comprising concentrated active ingredients
WO2005123133A1 (fr) * 2004-06-18 2005-12-29 Ranbaxy Laboratories Limited Procede de preparation de capsules gelatineuses molles d'ibuprofene
CA2570524C (fr) 2004-06-30 2013-01-15 Albemarle Corporation Granules a haute teneur en ibuprofene, preparation desdits granules et utilisation desdits granules dans des formes pharmaceutiques
US20060088590A1 (en) * 2004-10-22 2006-04-27 Banner Pharmacaps, Inc. Non-blooming gelatin and non-gelatin formulations
US8231896B2 (en) * 2004-11-08 2012-07-31 R.P. Scherer Technologies, Llc Non-gelatin soft capsule system
US20070053868A1 (en) 2005-03-08 2007-03-08 Banner Pharmacaps, Inc. Solvent system for enhancing the solubility of pharmaceutical agents
WO2007035448A2 (fr) * 2005-09-19 2007-03-29 Albemarle Corporation Solutions aqueuses versables fortement concentrées d'ibuprofène de potassium, leur préparation et leurs utilisations
CN100404031C (zh) * 2006-03-13 2008-07-23 浙江万联药业有限公司 含葡萄糖酸锌、布洛芬和马来酸氯苯那敏的软胶囊组合物
JP5553830B2 (ja) * 2008-07-21 2014-07-16 アルベマール・コーポレーシヨン 高含量イブプロフェンナトリウム顆粒、その調製、および非発泡性固体剤形を調製する際のその使用
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
ES2363964B1 (es) 2009-11-20 2012-08-22 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados.
CA2690488C (fr) 2010-01-19 2013-06-11 Accucaps Industries Limited Formulations pharmaceutiques de naproxen pour encapsulation molle et combinaisons associees
CN104083339A (zh) * 2014-08-04 2014-10-08 人福普克药业（武汉）有限公司 萘普生钠软胶囊及其制备方法
CN107951857B (zh) * 2017-11-29 2019-12-24 浙江安宝药业有限公司 布洛芬软胶囊
US11911517B2 (en) 2018-05-16 2024-02-27 Bayer Healthcare Llc High concentration suspension formulation for cold and flu soft gel capsule medications
WO2019224832A1 (fr) * 2018-05-25 2019-11-28 Strides Shasun Limited Procédé de préparation de compositions pharmaceutiques entrainant une réduction du volume de remplissage global pour une utilisation avec des formulations gélatineuses molles
CN108904465B (zh) * 2018-10-17 2021-02-26 石药集团恩必普药业有限公司 一种布洛芬药物制剂组合物及其制备方法
CN109820833B (zh) * 2019-04-01 2022-02-01 人福普克药业（武汉）有限公司 一种快速溶出的布洛芬软胶囊及其制备方法
BR112021021414A2 (pt) * 2019-04-26 2022-02-15 Scherer Technologies Llc R P Composição do mini softgel de naproxeno
WO2021072092A1 (fr) * 2019-10-09 2021-04-15 R.P. Scherer Technologies, Llc Formulations de capsules de gel mou non animal, procédés de préparation et procédés d'utilisation associés
US20220233452A1 (en) * 2021-01-25 2022-07-28 R.P. Scherer Technologies, Llc Mini softgel naproxen composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2118040A (en) 1982-02-15 1983-10-26 Hoechst Uk Ltd Oral anti-diabetic preparation
WO1985004106A1 (fr) 1984-03-14 1985-09-26 Corbiere Jerome Ppocede de solubilisation de principes actifs et compositions pharmaceutiques ainsi obtenues
DE3437599C2 (de) 1984-10-13 1987-04-16 Dolorgiet GmbH & Co KG, 5205 St Augustin Ibuprofen enthaltende Weichgelatinekapseln
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
JP3121080B2 (ja) 1991-12-19 2000-12-25 アール・ピー・シーラー コーポレイション カプセル封入用溶液
US5376688A (en) 1992-12-18 1994-12-27 R. P. Scherer Corporation Enhanced solubility pharmaceutical solutions
ATE300293T1 (de) * 1997-03-03 2005-08-15 Sanofi Aventis Pharmazeutische zusammensetzungen, die schwerlösliche arzneistoffe enthalten

Also Published As

Publication number Publication date
EP1365749A4 (fr) 2005-09-07
CY1106542T1 (el) 2012-01-25
HUP0401224A3 (en) 2008-04-28
HUP0401224A2 (hu) 2004-11-29
KR100634571B1 (ko) 2006-10-16
ES2206081T1 (es) 2004-05-16
TW589199B (en) 2004-06-01
HU229381B1 (en) 2013-11-28
CZ299449B6 (cs) 2008-07-30
BRPI0113539B1 (pt) 2017-05-09
KR20030041982A (ko) 2003-05-27
JP4990474B2 (ja) 2012-08-01
ZA200301007B (en) 2004-02-13
DE60126433D1 (de) 2007-03-22
PL365752A1 (en) 2005-01-10
NO20030897L (no) 2003-02-26
BRPI0113539B8 (pt) 2021-05-25
CA2419993C (fr) 2008-12-23
ATE353009T1 (de) 2007-02-15
WO2002017855A2 (fr) 2002-03-07
NO333369B1 (no) 2013-05-13
AU2431702A (en) 2002-03-13
JP2004526664A (ja) 2004-09-02
SI1365749T1 (sl) 2007-06-30
AU2002224317B2 (en) 2004-09-02
ES2206081T3 (es) 2007-10-01
EP1365749A2 (fr) 2003-12-03
PL200398B1 (pl) 2009-01-30
DE01984557T1 (de) 2004-04-22
CN1477953A (zh) 2004-02-25
CN1237959C (zh) 2006-01-25
MXPA03001762A (es) 2003-06-04
WO2002017855A3 (fr) 2003-09-25
EP1365749B1 (fr) 2007-01-31
DE60126433T2 (de) 2007-11-15
HK1056326A1 (en) 2004-02-13
BR0113539A (pt) 2003-07-15
PT1365749E (pt) 2007-03-30
CA2419993A1 (fr) 2002-03-07
NO20030897D0 (no) 2003-02-26
US6387400B1 (en) 2002-05-14

Similar Documents

Publication Publication Date Title
DK1365749T3 (da) Fremgangsmåde til fremstilling af farmaceutiske sammensætninger til anvendelse i blöde gelformuleringer
GEP20063741B (en) Nonaryl-Heterocyclic NMDA/NR2B Antagonists
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
HRP20020045A2 (en) Oral liquid compositions
GEP20033131B (en) Azabicycloalkanes as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Activity
ATE486587T1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
AR034813A1 (es) Composiciones farmaceuticas y uso de las mismas
IS7006A (is) Tvívetnis 3-piperidínóprópíófenon og lyf sem innihalda téð efnasambönd
BR0111678A (pt) Composições medicinais contendo derivados de propenona
WO2002024203A3 (fr) Formulation à administrer oralement à libération contrôlée
TR200101928T2 (tr) Geliştirilmiş kararlılığa sahip bileşimler
HUP0001104A2 (hu) Ibuprofent és domperidont tartalmazó készítmények migrén kezelésére
CA2466770A1 (fr) Compositions pharmaceutiques liquides d'acetaminophene et un sel de metal alcalin 1-lactate
GEP20043377B (en) Pharmaceutical Complex
PT1144420E (pt) Fosfatidilinositois sulfatados a sua preparacao e a sua utilizacao
MY133368A (en) Process for preparing pharmaceutical compositions for use with soft gelatin formulations
ATE194498T1 (de) Wasserfreies mittel auf lactulosebasis
AU2019203288A1 (en) Process for preparing pharmaceutical compositions resulting in reduction in overall fill volume for use with soft gelatin formulations
NO20001846L (no) Nye farmasøytisk aktive forbindelser, deres fremstilling og anvendelse som ECE-inhibitorer
DK0817643T3 (da) Forbindelser og præparater til administration af aktive midler
MY145885A (en) Controlled release formulations for oral administration
NO964775L (no) Fast farmasöytisk adenosinholdig preparat
AR032486A1 (es) Proceso para preparar composiciones para utilizar con formulaciones de gelatina blanda
BR9805026A (pt) Compostos contdndo tetrahidrolipstatina